Neothetics Stock Price, News & Analysis (NASDAQ:NEOT)

$1.92 0.08 (4.35 %)
(As of 01/18/2018 04:52 AM ET)
Previous Close$1.84
Today's Range$1.84 - $1.94
52-Week Range$0.30 - $2.63
Volume152,800 shs
Average Volume221,891 shs
Market Capitalization$26.58 million
P/E Ratio-2.78
Dividend YieldN/A
Beta3.33

About Neothetics (NASDAQ:NEOT)

Neothetics, Inc. is a clinical-stage specialty pharmaceutical company, which develops therapeutics. The Company focuses on localized fat reduction and body contouring. It focuses on the development of LIPO-202 for the reduction of central abdominal bulging due to subcutaneous fat in non-obese patients. LIPO-202 is a first-in-class injectable formulation of the long-acting Beta2-adrenergic receptor agonist, and salmeterol xinafoate, which is an active ingredient in the United States Food and Drug Administration inhaled products, such as SEREVENT DISKUS, ADVAIR HFA and ADVAIR DISKUS. The Company is developing a product candidate, LIPO-102, an injectable form of a combination of salmeterol xinafoate and fluticasone propionate. LIPO-102 is indicated for the treatment of the orphan indication of symptomatic exophthalmos, or protrusion of the eye from the orbit, associated with thyroid-related eye disease caused by the expansion of fat and muscle behind the eye.

Receive NEOT News and Ratings via Email

Sign-up to receive the latest news and ratings for NEOT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceuticals
Sub-IndustryN/A
SectorHealthcare
SymbolNASDAQ:NEOT
CUSIPN/A
Phone+1-858-7501008

Debt

Debt-to-Equity RatioN/A
Current Ratio4.41%
Quick Ratio4.41%

Price-To-Earnings

Trailing P/E Ratio-2.78260869565217
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book Value$0.86 per share
Price / Book2.23

Profitability

Trailing EPS($0.69)
Net Income$-13,010,000.00
Net MarginsN/A
Return on Equity-119.00%
Return on Assets-101.14%

Miscellaneous

Employees7
Outstanding Shares13,850,000

Neothetics (NASDAQ:NEOT) Frequently Asked Questions

What is Neothetics' stock symbol?

Neothetics trades on the NASDAQ under the ticker symbol "NEOT."

How were Neothetics' earnings last quarter?

Neothetics Inc (NASDAQ:NEOT) issued its quarterly earnings results on Wednesday, November, 8th. The biotechnology company reported ($0.13) EPS for the quarter. View Neothetics' Earnings History.

When will Neothetics make its next earnings announcement?

Neothetics is scheduled to release their next quarterly earnings announcement on Wednesday, March, 21st 2018. View Earnings Estimates for Neothetics.

Who are some of Neothetics' key competitors?

Who are Neothetics' key executives?

Neothetics' management team includes the folowing people:

  • Susan A. Knudson, Chief Financial Officer (Age 53)
  • Maria Feldman, Vice President, Clinical Operations, Regulatory Affairs and Quality Assurance (Age 52)
  • Kim P Kamdar, Lead Independent Director (Age 49)
  • Martha J. Demski, Independent Director (Age 64)
  • Maxim Gorbachev, Independent Director (Age 41)
  • Jeffrey M. Nugent, Independent Director (Age 70)

When did Neothetics IPO?

(NEOT) raised $60 million in an initial public offering on Thursday, November 20th 2014. The company issued 4,300,000 shares at a price of $13.00-$15.00 per share. Piper Jaffray and Guggenheim Securities served as the underwriters for the IPO and Needham & Company was co-manager.

How do I buy Neothetics stock?

Shares of Neothetics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Neothetics' stock price today?

One share of Neothetics stock can currently be purchased for approximately $1.92.

How big of a company is Neothetics?

Neothetics has a market capitalization of $26.58 million. The biotechnology company earns $-13,010,000.00 in net income (profit) each year or ($0.69) on an earnings per share basis. Neothetics employs 7 workers across the globe.

How can I contact Neothetics?

Neothetics' mailing address is 9171 Towne Centre Dr Ste 250, SAN DIEGO, CA 92122-1236, United States. The biotechnology company can be reached via phone at +1-858-7501008 or via email at [email protected]


MarketBeat Community Rating for Neothetics (NEOT)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  41 (Vote Outperform)
Underperform Votes:  39 (Vote Underperform)
Total Votes:  80
MarketBeat's community ratings are surveys of what our community members think about Neothetics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Neothetics (NASDAQ:NEOT) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Neothetics (NASDAQ:NEOT) Earnings History and Estimates Chart

Earnings by Quarter for Neothetics (NASDAQ:NEOT)

Neothetics (NASDAQ NEOT) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/21/2018N/AView Earnings Details
11/8/2017Q3 2017($0.13)ViewN/AView Earnings Details
8/10/2017Q2 2017($0.20)($0.20)ViewN/AView Earnings Details
5/11/2017Q1 2017($0.19)($0.22)ViewN/AView Earnings Details
3/23/2017Q4 2016($0.20)($0.14)ViewN/AView Earnings Details
11/10/2016Q3 2016($0.31)($0.17)ViewN/AView Earnings Details
8/11/2016Q2($0.40)($0.19)ViewN/AView Earnings Details
5/12/2016Q1($0.44)ViewN/AView Earnings Details
3/29/2016Q4($1.14)($0.69)ViewN/AView Earnings Details
11/12/2015Q315($0.84)($1.26)ViewN/AView Earnings Details
8/13/2015Q215($1.14)($0.69)ViewN/AView Earnings Details
5/14/2015Q115($0.93)($0.50)ViewN/AView Earnings Details
3/26/2015Q414($0.32)($0.45)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Neothetics (NASDAQ:NEOT) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Neothetics (NASDAQ:NEOT)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Neothetics (NASDAQ NEOT) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 39.20%
Institutional Ownership Percentage: 1.74%
Insider Trades by Quarter for Neothetics (NASDAQ:NEOT)

Neothetics (NASDAQ NEOT) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/30/2015Alta Partners Viii, L.P.InsiderSell797,987$1.51$1,204,960.37View SEC Filing  
12/29/2015Alta Partners Viii, L.P.Major ShareholderSell493,654$1.53$755,290.62View SEC Filing  
12/28/2015Alta Partners Viii, L.P.Major ShareholderSell54,333$1.59$86,389.47View SEC Filing  
12/17/2015Kenneth W. LockeInsiderSell598$1.26$753.48View SEC Filing  
12/17/2015Susan A. KnudsonCFOSell1,005$1.26$1,266.30View SEC Filing  
12/15/2015Alta Partners Viii, L.P.Major ShareholderSell529,261$1.44$762,135.84View SEC Filing  
11/18/2015Kenneth W. LockeinsiderSell6,098$8.30$50,613.40293View SEC Filing  
9/18/2015Christopher KemmererVPSell1,000$12.20$12,200.0010,848View SEC Filing  
9/1/2015Susan A. KnudsonCFOSell3,000$11.33$33,990.00492View SEC Filing  
3/19/2015George W MahaffeyCEOBuy1,000$7.76$7,760.00View SEC Filing  
11/25/2014Daniel JanneyDirectorSell149,286$14.00$2,090,004.00View SEC Filing  
11/25/2014Rmi Investments S.A.R.L.Major ShareholderBuy70,000$14.00$980,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Neothetics (NASDAQ NEOT) News Headlines

Source:
DateHeadline
Evofem Announces Closing Of Merger With NeotheticsEvofem Announces Closing Of Merger With Neothetics
finance.yahoo.com - January 17 at 5:32 PM
Neothetics Announces Adjournment of Special Stockholders Meeting to Solicit Additional Votes for Merger With EvofemNeothetics Announces Adjournment of Special Stockholders Meeting to Solicit Additional Votes for Merger With Evofem
finance.yahoo.com - January 16 at 5:22 PM
Pfenex (PFNX) Appoints Susan Knudson as CFOPfenex (PFNX) Appoints Susan Knudson as CFO
www.streetinsider.com - January 4 at 5:25 PM
Should You Be Concerned About Neothetics Inc’s (NEOT) Risks?Should You Be Concerned About Neothetics Inc’s (NEOT) Risks?
finance.yahoo.com - December 8 at 5:18 PM
Who Are The Major Shareholders In Neothetics Inc (NEOT)?Who Are The Major Shareholders In Neothetics Inc (NEOT)?
finance.yahoo.com - November 30 at 9:53 AM
Neothetics, Inc. (NEOT) Short Interest Down 53.7% in NovemberNeothetics, Inc. (NEOT) Short Interest Down 53.7% in November
www.americanbankingnews.com - November 29 at 1:34 AM
Neothetics, Inc. (NEOT) Issues Quarterly  Earnings ResultsNeothetics, Inc. (NEOT) Issues Quarterly Earnings Results
www.americanbankingnews.com - November 10 at 7:09 PM
Neothetics Provides Business Update and Reports Third Quarter 2017 Financial ResultsNeothetics Provides Business Update and Reports Third Quarter 2017 Financial Results
globenewswire.com - November 9 at 7:44 AM
Neothetics, Inc. (NEOT) Set to Announce Earnings on WednesdayNeothetics, Inc. (NEOT) Set to Announce Earnings on Wednesday
www.americanbankingnews.com - November 1 at 4:28 AM
Neothetics, How Will EvoFem Merger Impact ShareholdersNeothetics, How Will EvoFem Merger Impact Shareholders
finance.yahoo.com - October 25 at 8:04 AM
Have Investors Already Priced In Healthcare Growth For Neothetics Inc (NEOT)?Have Investors Already Priced In Healthcare Growth For Neothetics Inc (NEOT)?
finance.yahoo.com - October 24 at 7:34 AM
Neothetics (NEOT) to Merge with Evofem BiosciencesNeothetics (NEOT) to Merge with Evofem Biosciences
www.streetinsider.com - October 19 at 6:44 AM
BRIEF-Neothetics Inc and Evofem Biosciences Inc announce merger agreement to create Women’S health companyBRIEF-Neothetics Inc and Evofem Biosciences Inc announce merger agreement to create Women’S health company
www.reuters.com - October 19 at 6:44 AM
Neotheticss stock rockets on heavy volume after merger dealNeothetics's stock rockets on heavy volume after merger deal
finance.yahoo.com - October 18 at 7:30 AM
ValuEngine Upgrades Neothetics, Inc. (NEOT) to "Sell"ValuEngine Upgrades Neothetics, Inc. (NEOT) to "Sell"
www.americanbankingnews.com - October 17 at 11:38 PM
Neothetics, Inc. (NEOT) Short Interest UpdateNeothetics, Inc. (NEOT) Short Interest Update
www.americanbankingnews.com - October 14 at 1:40 AM
Biotech Stocks on Investors Radar -- Neothetics, Pieris Pharma, and Repros TherapeuticsBiotech Stocks on Investors' Radar -- Neothetics, Pieris Pharma, and Repros Therapeutics
www.marketwatch.com - September 28 at 12:43 PM
Neothetics Inc (NEOT): How Does It Impact Your Portfolio?Neothetics Inc (NEOT): How Does It Impact Your Portfolio?
finance.yahoo.com - September 19 at 2:38 AM
Short Interest in Neothetics, Inc. (NEOT) Increases By 48.6%Short Interest in Neothetics, Inc. (NEOT) Increases By 48.6%
www.americanbankingnews.com - August 28 at 1:20 AM
BRIEF-Neothetics posts Q2 loss per share $0.20BRIEF-Neothetics posts Q2 loss per share $0.20
www.reuters.com - August 12 at 8:14 PM
Neothetics, Inc. (NEOT) Releases  Earnings Results, Meets EstimatesNeothetics, Inc. (NEOT) Releases Earnings Results, Meets Estimates
www.americanbankingnews.com - August 11 at 7:54 PM
Neothetics Provides Business Update and Reports Second Quarter 2017 Financial ResultsNeothetics Provides Business Update and Reports Second Quarter 2017 Financial Results
finance.yahoo.com - August 11 at 6:53 AM
Neothetics Announces Review of Strategic AlternativesNeothetics Announces Review of Strategic Alternatives
finance.yahoo.com - July 11 at 3:27 AM
Neothetics stock plummets 66% on news of negative results for fat-reduction drugNeothetics stock plummets 66% on news of negative results for fat-reduction drug
www.marketwatch.com - June 27 at 6:53 PM
Neothetics Inc. (NEOT) Sank To A 10-Month Low After Phase 2 Study FailedNeothetics Inc. (NEOT) Sank To A 10-Month Low After Phase 2 Study Failed
www.rttnews.com - June 27 at 6:53 PM
NEOTHETICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsNEOTHETICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
biz.yahoo.com - April 3 at 6:07 PM
Q4 2016 Neothetics Inc Earnings Release - Before Market OpenQ4 2016 Neothetics Inc Earnings Release - Before Market Open
us.rd.yahoo.com - March 23 at 7:18 PM
Neothetics Provides Business Update and Reports Fourth Quarter 2016 Financial ResultsNeothetics Provides Business Update and Reports Fourth Quarter 2016 Financial Results
us.rd.yahoo.com - March 23 at 7:18 PM
NEOTHETICS, INC. Files SEC form 8-K, Change in Directors or Principal OfficersNEOTHETICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
biz.yahoo.com - March 7 at 6:37 PM
Form SC 13G/A Neothetics, Inc. Filed by: DRILL CRAIG AForm SC 13G/A Neothetics, Inc. Filed by: DRILL CRAIG A
www.streetinsider.com - January 6 at 7:29 PM
Neothetics (NEOT) Begins Phase II Study on Lead CandidateNeothetics (NEOT) Begins Phase II Study on Lead Candidate
www.zacks.com - December 28 at 10:05 AM
Neothetics (NEOT) Phase 2 Proof of Concept Trial for LIPO-202 Initiated for Double ChinNeothetics (NEOT) Phase 2 Proof of Concept Trial for LIPO-202 Initiated for Double Chin
www.streetinsider.com - December 24 at 6:18 PM
Neothetics (NEOT) Leaped as New Drug Trial CommencesNeothetics (NEOT) Leaped as New Drug Trial Commences
www.baystreet.ca - December 23 at 8:17 PM
NEOTHETICS, INC. Files SEC form 8-K, Termination of a Material Definitive AgreementNEOTHETICS, INC. Files SEC form 8-K, Termination of a Material Definitive Agreement
biz.yahoo.com - September 23 at 5:55 PM
Neothetics Provides Business Update and Reports Second Quarter 2016 Financial ResultsNeothetics Provides Business Update and Reports Second Quarter 2016 Financial Results
www.nasdaq.com - August 11 at 9:37 AM
NEOTHETICS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security HoldersNEOTHETICS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
biz.yahoo.com - June 17 at 8:01 AM
NEOTHETICS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard;NEOTHETICS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard;
biz.yahoo.com - June 6 at 8:01 AM
NEOTHETICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsNEOTHETICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
biz.yahoo.com - May 12 at 8:01 AM
Q1 2016 Neothetics Inc Earnings Release - Before Market OpenQ1 2016 Neothetics Inc Earnings Release - Before Market Open
biz.yahoo.com - May 12 at 7:07 AM
NEOTHETICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or PrincipalNEOTHETICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or Principal
biz.yahoo.com - February 18 at 4:08 PM
Why Neothetics Is Getting DestroyedWhy Neothetics Is Getting Destroyed
247wallst.com - December 15 at 1:15 PM
NEOTHETICS, INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsNEOTHETICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
biz.yahoo.com - December 14 at 5:02 PM
NEOTHETICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other EventsNEOTHETICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events
biz.yahoo.com - December 10 at 4:39 PM
NEOTHETICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and ExhibitsNEOTHETICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
biz.yahoo.com - December 1 at 5:21 PM

SEC Filings

Neothetics (NASDAQ:NEOT) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Neothetics (NASDAQ:NEOT) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Neothetics (NASDAQ NEOT) Stock Chart for Thursday, January, 18, 2018

Loading chart…

This page was last updated on 1/18/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.